Global Liver Institute is thrilled to share that the Centers for Medicare & Medicaid Services (CMS) has proposed to align coverage policy to reflect the understanding that obesity is a chronic disease.
Global Liver Institute
GLOBAL LIVER INSTITUTE
Healthy Holidays! Gut Friendly Tips and Liver Health Innovations – Liver Cancer News
Welcome back to this special holiday edition of Liver Cancer News! As the festive season begins, read on to discover articles on liver cancer health, the latest management tools, and recent innovations.
Global Liver Institute Acknowledges FDA Request for Further Studies as Obeticholic Acid Remains Available for PBC Patients
Global Liver Institute (GLI) acknowledges the U.S. Food and Drug Administration’s (FDA) decision today to issue a Complete Response Letter (CRL) for the supplemental New Drug Application (sNDA) of obeticholic acid (OCA, OCALIVA®) for primary biliary cholangitis (PBC).
After elections, a lame-duck Congress will need to pass appropriations bills and hopefully “clear the decks” by passing long-awaited health reforms – Liver Health Policy Update
Members of Congress will return to Washington, DC, after the elections. Hopes remain for a productive November legislative session where some legislative priorities may finally make it to final passage.
Uniting for Equity in Liver Cancer Care – Liver Cancer News
In October, Global Liver Institute led its annual #OctoberIs4Livers campaign, focused on health equity and raising awareness about liver cancer.
Innovation Sparks New Ideas at NORD’s Breakthrough Summit – Pediatric & Rare Liver Diseases News
Kristin Hatcher spent three days in Washington, D.C., at the NORD Breakthrough Summit to discuss equitable access to innovation.
Screening for MASLD is Cost-Effective for Patients – Fatty Liver Disease News
In this issue, we explore recent findings that highlight the need for dietary changes, including the link between ultra-processed foods and metabolic disorders in children with obesity, as well as the benefits of increasing plain water intake can reduce mortality risk.
Terri’s Story
When my doctor told me that I had fatty liver disease in 2015, the communication was that it was no big deal. In 2016, I was diagnosed with lupus then pancreatitis. Eventually, the pain, discomfort and fatigue from gallstones led me to an elective gallbladder surgery in 2017. During the surgery, my well-meaning surgeon found my liver to be nodular and decided to biopsy three separate spots while in the process of removing my gallbladder. What my surgeon did not know is how that biopsy would trigger a series of complications for my fragile liver.
Why Hepatitis C Treatment Matters: Improving Patient Outcomes Beyond Liver Health
Hepatitis C continues to be a significant public health concern with effects that reach beyond liver function. As a physician, you’re likely familiar with the chronic health challenges that accompany hepatitis C, especially in patients with multiple comorbidities.
Congress goes into recess in October while staff prepare for a potentially busy November lame-duck session – Liver Health Policy Update
Congress is in recess with Representatives and Senators back in districts and states connecting with their constituents prior to the elections. Their staff are working hard to prepare for what many hope to be a productive November legislative session where some legislative priorities may finally make it to final passage.
Cancer Care for the Underrepresented #Octoberis4Livers – Liver Cancer News
Welcome back to Liver Cancer News! As we mark Liver Cancer Awareness Month in October, we’re emphasizing the critical role of education and awareness in the fight against liver cancer through the #OctoberIs4Livers campaign. Read on for more information about the campaign and for updates on liver cancer care & prevention – especially for populations that face disparities in liver cancer care.
Emerging Evidence in Liver Health: GLP-1, Pollution, and More – Fatty Liver Disease News
Despite awareness efforts, fatty liver disease remains largely overlooked in major global health strategies.